Found: 27
Select item for more details and to access through your institution.
Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5- HT<sub>3</sub> Receptor Antagonists for the Management of Depression.
- Published in:
- Chemical Biology & Drug Design, 2014, v. 84, n. 6, p. 721, doi. 10.1111/cbdd.12370
- By:
- Publication type:
- Article
Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2-Methoxy 1, 8 Naphthyridine 3-Carboxamides as 5- HT<sub>3</sub> Receptor Antagonists.
- Published in:
- Chemical Biology & Drug Design, 2014, v. 83, n. 5, p. 583, doi. 10.1111/cbdd.12271
- By:
- Publication type:
- Article
Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats.
- Published in:
- Indian Journal of Psychological Medicine, 2013, v. 35, n. 3, p. 290, doi. 10.4103/0253-7176.119501
- By:
- Publication type:
- Article
Antithrombotic Effects due to Pharmacological Modulation of Thrombin-Activatable Fibrinolysis Inhibitor in Rats.
- Published in:
- Pharmacology, 2008, v. 82, n. 4, p. 304, doi. 10.1159/000165118
- By:
- Publication type:
- Article
Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT<sub>3</sub> Receptor Antagonists with Antidepressant-Like Activity.
- Published in:
- Archiv der Pharmazie, 2015, v. 348, n. 1, p. 34, doi. 10.1002/ardp.201400293
- By:
- Publication type:
- Article
Ligand-Based Design, Synthesis, and Pharmacological Evaluation of 3-Methoxyquinoxalin-2-carboxamides as Structurally Novel Serotonin Type-3 Receptor Antagonists.
- Published in:
- Archiv der Pharmazie, 2012, v. 345, n. 9, p. 687, doi. 10.1002/ardp.201200038
- By:
- Publication type:
- Article
Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 2, p. 335, doi. 10.1007/s11011-023-01314-3
- By:
- Publication type:
- Article
Targeting inflammation: a potential approach for the treatment of depression.
- Published in:
- Metabolic Brain Disease, 2023, v. 38, n. 1, p. 45, doi. 10.1007/s11011-022-01095-1
- By:
- Publication type:
- Article
Ameliorative Potential of Rosuvastatin on Doxorubicin-induced Cardiotoxicity by Modulating Oxidative Damage in Rats.
- Published in:
- Turkish Journal of Pharmaceutical Sciences, 2022, v. 19, n. 1, p. 28, doi. 10.4274/tjps.galenos.2021.70745
- By:
- Publication type:
- Article
Effect of combination of ketanserin and escitalopram on behavioral anomalies after olfactory bulbectomy: Prediction of quick onset of antidepressant action.
- Published in:
- Indian Journal of Pharmacology, 2014, v. 46, n. 6, p. 639, doi. 10.4103/0253-7613.144935
- By:
- Publication type:
- Article
Neuropharmacological evaluation of a novel 5-HT<sub>3</sub> receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice.
- Published in:
- Indian Journal of Pharmacology, 2014, v. 46, n. 2, p. 191, doi. 10.4103/0253-7613.129316
- By:
- Publication type:
- Article
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests.
- Published in:
- Indian Journal of Pharmacology, 2013, v. 45, n. 4, p. 348, doi. 10.4103/0253-7613.115014
- By:
- Publication type:
- Article
Anxiolytic-like effect of (4-benzylpiperazin-1-yl) (3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety.
- Published in:
- Indian Journal of Pharmacology, 2013, v. 45, n. 3, p. 248, doi. 10.4103/0253-7613.111923
- By:
- Publication type:
- Article
Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT<sub>3</sub> receptor antagonist: An investigation in behaviour-based rodent models of depression.
- Published in:
- Indian Journal of Pharmacology, 2012, v. 44, n. 5, p. 560, doi. 10.4103/0253-7613.100371
- By:
- Publication type:
- Article
Antidepressant-and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1,8-naphthyridine -3-carboxylic acid (7e)-: An approach using rodent behavioral antidepressant and anxiolytic test battery.
- Published in:
- International Journal of Nutrition, Pharmacology, Neurological Diseases, 2016, v. 6, n. 2, p. 81, doi. 10.4103/2231-0738.179968
- By:
- Publication type:
- Article
Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potential.
- Published in:
- International Journal of Nutrition, Pharmacology, Neurological Diseases, 2013, v. 3, n. 4, p. 383, doi. 10.4103/2231-0738.119855
- By:
- Publication type:
- Article
ACTIVATION OF TWEAK/FN14 SIGNALING SUPPRESSES TRAFS/NF-ΚB PATHWAY IN THE PATHOGENESIS OF CANCER.
- Published in:
- EXCLI Journal, 2020, p. 232, doi. 10.17179/excli2021-3378
- By:
- Publication type:
- Article
Retraction Note: Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: Novel 5-HT<sub>3</sub> receptor antagonists with anxiolytic-like activity in rodent behavioral models.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2013, v. 91, n. 10, p. 848, doi. 10.1139/cjpp-2013-0134
- By:
- Publication type:
- Article
Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1245809
- By:
- Publication type:
- Article
Nanosizing Approaches: Current Trends in the Solubility Enhancement of Poorly Water-soluble Drugs.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 3, p. 625, doi. 10.5530/ijper.57.3.77
- By:
- Publication type:
- Article
Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies.
- Published in:
- 3 Biotech, 2021, v. 11, n. 6, p. 1, doi. 10.1007/s13205-021-02811-x
- By:
- Publication type:
- Article
Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.
- Published in:
- Psychopharmacology, 2015, v. 232, n. 3, p. 623, doi. 10.1007/s00213-014-3705-0
- By:
- Publication type:
- Article
Targeting natural products against SARS-CoV-2.
- Published in:
- Environmental Science & Pollution Research, 2022, v. 29, n. 28, p. 42404, doi. 10.1007/s11356-022-19770-2
- By:
- Publication type:
- Article
Investigation of Cochlospermum religiosum leaves for antidepressant and anxiolytic activities and its synergistic effect with imipramine and fluoxetine.
- Published in:
- Environmental Science & Pollution Research, 2022, v. 29, n. 18, p. 27172, doi. 10.1007/s11356-021-18359-5
- By:
- Publication type:
- Article
Neuropharmacological and neurochemical evaluation of N -n -propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT<sub>3</sub> receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2017, v. 28, n. 2, p. 93, doi. 10.1515/jbcpp-2016-0057
- By:
- Publication type:
- Article
Neuropharmacological evaluation of a novel 5-HT<sub>3</sub> receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2017, v. 28, n. 2, p. 101, doi. 10.1515/jbcpp-2016-0083
- By:
- Publication type:
- Article